NCT07083076 Regular Diet Versus Extended Low Residue After Colon Surgery
| NCT ID | NCT07083076 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwell Health |
| Condition | Colon Resection |
| Study Type | INTERVENTIONAL |
| Enrollment | 222 participants |
| Start Date | 2025-09-19 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 222 participants in total. It began in 2025-09-19 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a 10 day low-residue diet restriction is better for bowel function and quality of life without increasing complications compared to a 6 week low-residue diet restriction after elective colon resection surgery. The main questions it aims to answer are: Does a shorter time period of low residue restriction result in a faster return to normal bowel function? Are there any differences in complication rate between a 10 day low-residue diet restriction compared to a 6 week low-residue diet restriction? Participants will be randomized to one of the two diet plans and will be asked to answer surveys about their bowel function and health care related quality of life at various time points for up to 3 months.
Eligibility Criteria
Inclusion Criteria: * Adult patients who have elective colon resection with anastomosis Exclusion Criteria: * Patients who have an ostomy as part of their surgery * Patients who undergo emergency surgery * Patients who do not follow the enhanced recovery protocol (the standard postoperative protocol for patients undergoing elective colon resection) * Patients less than 18 years of age * Vulnerable populations: fetuses, pregnant women, children, cognitively impaired, hospital employees, students, healthy controls, prisoners, and other institutionalized individuals
Contact & Investigator
Andrea Zimmern, MD
PRINCIPAL INVESTIGATOR
Northwell Health
Frequently Asked Questions
Who can join the NCT07083076 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colon Resection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07083076 currently recruiting?
Yes, NCT07083076 is actively recruiting participants. Contact the research team at azimmern@northwell.edu for enrollment information.
Where is the NCT07083076 trial being conducted?
This trial is being conducted at Manhasset, United States, New Hyde Park, United States.
Who is sponsoring the NCT07083076 clinical trial?
NCT07083076 is sponsored by Northwell Health. The principal investigator is Andrea Zimmern, MD at Northwell Health. The trial plans to enroll 222 participants.